% Adjusted EBITDA(1) 254 146 74% 253 0.4% 507 361 40% Adjusted EBITDA Margin (%) 6.5% 4.4% 2.1% 4.8% 1.7% 5.5% 5.9% -0.4% Net Profit -344 -36 856% 239 -244% -105 -16 556% Extra Item(2) - 14 -100% - N/A - 16

quarter of 2021, the operating results of the company and its subsidiaries showed the net profit of Baht 560.5 million, increased by 174.5% when compared to the fourth quarter of 2020 with the net profit of

services 70.23 134.10 (63.87) (47.63) 187.30 255.80 (68.50) (26.78) Cost of services (69.11) (120.99) (51.87) (42.88) (178.34) (235.23) (56.89) (24.19) Gross profit (loss) 1.12 13.11 (12.00) (91.48) 8.96

1,359 MB increased from 9M/2016 which was at 885 MB. However, the company’s performance was still impacted from Stock Loss and appreciating Baht currency which resulted in the reported net profit in

deeper services with targeted and measurable advertising. With the above-mentioned developments, we once again reported biggest quarterly revenue and profit in corporate history in 4Q 2017 (3 quarters

trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from

days 69 72 63 Cash Conversion Cycle days 81 75 66 Finanial data and profitability ratios Sales revenues million baht 49,269 46,887 46,938 %change (%) 5.1% (0.11%) 6.51% Gross profit million baht 12,547

1,821 2,480 -26.6 4,316 4,931 -12.5 Selling and administrative expenses 341 330 3.3 646 645 0.2 Total expenses 2,162 2,810 -23.1 4,962 5,576 -11.0 Profit before finance cost and tax expenses 671 4,732

2.55 0.25% (21.41) (5.73%) 23.96 111.91% 44.15 4.26% (41.60) 94.22% Cost of Service 0.00 0.00% (5.91) (767.53%) 5.91 100.00% (7.10) (144.90%) 7.10 100.00% Gross Profit (Loss) 84.63 8.21% (61.03) (16.31

149.07 122.57 26.50 21.6% Gross profit 52.39 58.64 -6.24 -10.6% Gross profit margin 26% 32% SG&A 41.26 39.14 2.12 5.4% EBIT 12.35 21.95 -8.36 -38.1% EBITDA 32.77 47.66 -14.88 -31.2% EBITDA margin 16% 26